A strict new vaccine approval process in the U.S. could dramatically slow things down for biopharma and the public, experts ...
Republican worries about losing their majority in the U.S. House of Representatives next year erupted this week, when four ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results